Skip to content

Multi-centre risk-based screening for diabetes and its complications

Translating research into clinical and community practice: a multi-centre statistical and economical modelling of risk-based stratified and personalised screening for complications of diabetes in India (SMART India).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN57962668
Enrollment
48000
Registered
2018-09-24
Start date
2018-08-25
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Nutritional, Metabolic, Endocrine Diabetes mellitus

Interventions

Trialists will identify 3 separate clusters of urban, rural and a special population per 20 regions in India. They will visit 2000 consecutive homes in each cluster to invite the adult family members

Sponsors

Vision Research Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older 2. Able to give informed consent

Exclusion criteria

Exclusion criteria: 1. Vulnerable adults in whom it may not be possible to carry out all tests 2. Anyone in the opinion of the health worker deemed not appropriate to be screened

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy and sensitivity of non-laboratory versus laboratory tests to diagnose pre-diabetes and diabetes, assessed at the study visit by the proportion of people who test positive for diabetes (true positive rate) and the proportion of test negatives who are true negatives (negative predictive value). The accuracy of non-laboratory tests will be defined by the results of standard diabetes diagnostic tests.

Secondary

MeasureTime frame
The following are assessed at the study visit: 1. Specificity (true negative rate): 1.1. The proportion of people who do not have diabetes who test negative in blood tests 1.2. The proportion of people who do not have microalbuminuria who test negative in urine tests 1.3. The proportion of people who do not have diabetic retinopathy who test negative in retinal imaging 1.4. The proportion of people who do not have increased blood pressure and/or blood lipids who test negative in blood tests 1.5. The proportion of people who do not have more than one complication of diabetes who test negative in blood tests 2. Sensitivity (true positive rate): 2.1. Microalbuminuria: 2.1.1. The proportion of people who test positive for microalbuminuria 2.1.2. Accuracy of the non-laboratory test (index test) will be defined by the results of the standard panel of diagnostic tests for microalbuminuria 2.2. Diabetic retinopathy: 2.2.1. The proportion of people who test positive for diabetic retinopathy 2.2.2. Accuracy of the non-laboratory test (index test) will be defined by the results of the standard panel of diagnostic tests for diabetic retinopathy and complications of diabetes 2.3. Blood pressure and/or blood lipids: 2.3.1. The proportion of people who test positive for increased blood pressure and/or blood lipids 2.3.2. Accuracy of the non-laboratory test (index test) will be defined by the results of the standard panel of diagnostic tests for macrovascular complications of diabetes 3. Cost-effectiveness of non-laboratory tests or alternate tests compare to standard blood tests for diabetes diagnosis 4. Test acceptability, assessed using a short questionnaire comparing the acceptability of non-lab

Countries

India

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 17, 2026